Divi Coins wants to make their cryptocurrency as convenient and accessible as possible. The Divi Project is a new crypto company that closed their initial coin sale in November. The new crypto is looking to replace exchanges like Paypal or Venmo.
Geoff McCabe is the Co-founder and CEO at The Divi Project Tim Sanders is the CMO at The Divi Project. The pair joined Cheddar to explain why they think their new cryptocurrency will lead the market. Sanders stresses that as a company, Divi is attentive and responsive to their consumers' needs.
McCabe believes that in the future all cryptocurrencies will be interchangeable and exchanged via digital wallets. So for Divi, the key is to be adopted and trusted by as many people as possible. In terms of future steps, The Divi Project is looking to build out their own blockchain and wallet.
These are the headlines you Need 2 Know for Tuesday, Feb. 19, 2019.
Canopy Growth CEO Bruce Linton won't guarantee investors dividends. What he will promise is a stake in global cannabis domination. "If people want a dividend, we are probably not the right stock. If they want some entity aimed at dominating a global opportunity that started in Canada, we are probably your best bet," Linton told Cheddar on Friday, one day after the company reported a massive spike in third-quarter revenue.
These are the headlines you Need 2 Know for Friday, Feb, 15, 2019.
It's a big week in cannabis earnings ー Aurora Cannabis reported Monday and Canopy Growth will report Thursday ー but Paul Rosen, CEO of cannabis private equity firm Tidal Royalty, said he's noticing a concerning trend."All the companies are facing gross margin compression because there are excise taxes, there's a massive marketing spend as we go to recreational cannabis, and there's also increased packaging costs. So I think you're going to see a trend line here, which is revenue and capacity going up, but gross margin is going down," Rosen told Cheddar Wednesday.
Opiant Pharmaceuticals, the developer of opioid antidote NARCAN, is in the process of developing a version of its lifesaving drug for cannabanoid overdoses, the company's CEO told Cheddar in an interview on Wednesday.
The theme of Bill and Melinda Gates' annual letter for 2019 is "surprise." The letter, released Tuesday, acts as a roadmap for how the Gates Foundation plans to invest in technology that will help make the world a better place in the years to come. And, as Melinda Gates told Cheddar in an interview, it starts with poop.
There's a dearth of research to back up the abundance of miraculous health claims tied to CBD ー but that won't stop celebrities from endorsing it. CBD, or cannabidiol, is a component of cannabis or hemp with little to no psychotropic effects. It is purported to have an array of applications to treat everything from epilepsy to anxiety, pain, depression, and sleeplessness. When Congress and President Trump signed the latest version of the Farm Bill into effect, they also legalized hemp, and thereby CBD derived from hemp.
More than 50 years after the psychedelic Summer of Love, psilocybin, the psychoactive component in magic mushrooms, is having a moment. Researchers at leading universities have been conducting research on the purported medical benefits of mushrooms for years, but as studies yield promising results, the opioid epidemic persists and sentiment warms toward cannabis, mushrooms are earning a lot more attention. Lawmakers and psychotropic advocates have concurrently advanced separate measures in Oregon, Colorado, and, most recently, Iowa, that attempt to loosen restrictions on these hallucinogenic fungi.
These are the headlines you Need 2 Know for Thursday, Feb. 7, 2019.
These are the headlines you Need 2 Know for Wednesday, Feb, 6, 2019.
